Breaking News, Promotions & Moves

Capsida Biotherapeutics Names Susan Catalano Chief Scientific Officer

Catalano brings more than two decades of experience leading discovery, translational science and clinical functions.

Capsida Biotherapeutics has appointed Susan Catalano Chief Scientific Officer (CSO). According to the company, Catalano will continue to build on Capsida’s foundation of excellence in next-generation gene therapy science together with co-founders Nicholas Flytzanis, Ph.D. and Nick Goeden, Ph.D., to advance the company’s pipeline into the clinic. Catalano brings more than two decades of experience leading discovery, translational science and clinical functions to bring mult...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters